Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS medicine, 21
Pathogen diversity and antimicrobial resistance transmission of Salmonella enterica serovars Typhi and Paratyphi A in Bangladesh, Nepal, and Malawi: a genomic epidemiological study.
Dyson ZA. et al, (2024), The Lancet. Microbe, 5
A retrospective investigation of the population structure and geospatial distribution of Salmonella Paratyphi A in Kathmandu, Nepal.
Mylona E. et al, (2024), PLoS neglected tropical diseases, 18
Mismanagement of Patients with High Altitude Illness Evacuated from the Mount Everest Region in Nepal.
Pant SR. et al, (2024), High altitude medicine & biology
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Schumacher AE. et al, (2024), The Lancet, 403, 1989 - 2056
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Naghavi M. et al, (2024), The Lancet, 403, 2100 - 2132
The facilitators of and barriers to antimicrobial use and misuse in Lalitpur, Nepal: a qualitative study.
Udas S. et al, (2024), BMC public health, 24
High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
Peto L. et al, (2024), Lancet (London, England), 403, 1339 - 1340
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990–2019: a modelling study
Browne AJ. et al, (2024), The Lancet Global Health, 12, e406 - e418
Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age
Bijukchhe SM. et al, (2024), Vaccine, 42, 2018 - 2025
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
Faust SN. et al, (2024), The Lancet Child & Adolescent Health, 8, 190 - 200
The Identification of Enteric Fever-Specific Antigens for Population-Based Serosurveillance.
Mylona E. et al, (2024), The Journal of infectious diseases, 229, 833 - 844
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Abani O. et al, (2023), The Lancet Diabetes & Endocrinology, 11, 905 - 914
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Salmonella Typhi genomes
Carey ME. et al, (2023), eLife, 12